Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
in nearly every area of health. We are home to five Nobel laureates who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse
-
every area of health. We are home to five Nobel laureates who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community made of
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 2 days ago
expanded significantly in size, funding, and scope, contributing to advances in emerging fields such as stem cell biology, RNA interference, and gene therapy. The mission of the Department of Pharmacology is
-
are home to five Nobel laureates who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community made of people with many skills and
-
advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community made of people with many skills and talents. We seek candidates whose work
-
of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community made of people with many skills and talents. We seek candidates whose work experience or community service
-
advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community made of people with many skills and talents. We seek candidates whose work
-
the following key topics: Molecular mechanisms governing the lineage plasticity of lung stem cells. Intercellular crosstalk between lung stem cells and their niche. Inflammatory memory of lung stem cells during
-
experts in nearly every area of health. We are home to five Nobel laureates who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse
-
(e.g. stem cell therapy). Funding for the program includes ~$10M per year in basic and translational science research grants and contracts, and $500K per year in Departmental endowment and other funds